TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC)

NCT01903252 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

817

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ulcerative Colitis

Interventions

DRUG: TP05
DRUG: Asacol 400 mg

Sponsor

Tillotts Pharma AG